Abstract, Snapshot, Market Analysis & Market Definition: World Dry Powder Inhaler Device Market
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.The global total sales of dry powder inhaler device is nearly 49674 K units in 2015. In 2019, the market size of Dry Powder Inhaler Device is 675.7 million US$ and it will reach 942.6 million US$ in 2025, growing at a CAGR of 4.9% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dry Powder Inhaler Device. This report studies the global market size of Dry Powder Inhaler Device, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India, and Southeast Asia). This study presents the Dry Powder Inhaler Device production, revenue, market share, and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019
Market Segmentation, Outlook & Viewpoint: World Dry Powder Inhaler Device Market
Segmentation by Product Type: Breakdown of data from the year 2014 to 2019 and forecast until 2025: Single Dose
Multi-dose
Segmentation by Application: Breakdown of data from the year 2014 to 2019 and forecast until 2025:
Asthma
COPD
Other
Top Companies & Key Players: World Dry Powder Inhaler Device Market
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Key Insights Covered: World Dry Powder Inhaler Device Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue, and growth rate) of Dry Powder Inhaler Device industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate, and gross margin) of Dry Powder Inhaler Device industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Dry Powder Inhaler Device industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Dry Powder Inhaler Device industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Dry Powder Inhaler Device industry.
Research Methodology: Global Dry Powder Inhaler Device Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.